Dashboard E. coli
Repurposing candidates for E. coli
Escherichia coli
Approved medicines with AI-predicted activity ≥40% against E. coli, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 467
- Existing antimicrobials set aside
- 103
- Needing review
- 28
- Repurposing candidates
- 336
Repurposing candidates for E. coli
AI prediction · nothing measuredAll 336 repurposing candidates for E. coli.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Nirogacestat HydrobromideExisting use: Gastrointestinal desmoid tumor47.9% AI-predicted activityagainst E. coli1 registered study
- Naratriptan HydrochlorideExisting use: Migraine disorder47.7% AI-predicted activityagainst E. coli4 registered studies
- Tepotinib HydrochlorideExisting use: Cancer, Neoplasm, Non-small cell lung carcinoma47.7% AI-predicted activityagainst E. coli6 registered studies
- Cobimetinib FumarateExisting use: Cancer, Melanoma, Metastatic melanoma and 1 more47.6% AI-predicted activityagainst E. coliNo documented evidence found
- RevefenacinExisting use: Airway obstruction, Chronic obstructive pulmonary disease47.5% AI-predicted activityagainst E. coli20 registered studies
- SotorasibExisting use: Neoplasm, Non-small cell lung carcinoma47.3% AI-predicted activityagainst E. coli50+ registered studies
- Vincristine SulfateExisting use: Neoplasm47.2% AI-predicted activityagainst E. coli50+ registered studies
- BrexpiprazoleExisting use: Major depressive disorder, Psychosis, Schizoaffective disorder and 1 more47.2% AI-predicted activityagainst E. coli50+ registered studies
- Octreotide AcetateExisting use: Acromegaly, Carcinoid tumor, Metastasis and 1 more47.0% AI-predicted activityagainst E. coli50+ registered studies
- DeserpidineExisting use: Hypertension47.0% AI-predicted activityagainst E. coliNo documented evidence found
- Ioflupane I-123Existing use: Abnormality of movement, Alzheimer disease, Computed tomography and 7 more47.0% AI-predicted activityagainst E. coli36 registered studies
- Montelukast SodiumExisting use: Airway obstruction, Allergic rhinitis, Asthma and 2 more46.9% AI-predicted activityagainst E. coli50+ registered studies
- DanicopanExisting use: Acquired paroxysmal nocturnal hemoglobinuria, Hemoglobinuria, Paroxysmal, Hemolysis46.9% AI-predicted activityagainst E. coli30 registered studies
- TipranavirExisting use: Hemorrhage, HIV infection, Viral disease46.9% AI-predicted activityagainst E. coli50+ registered studies
- ItraconazoleExisting use: Aspergillosis, Blastomycosis, Candidiasis and 4 more46.9% AI-predicted activityagainst E. coli50+ registered studies
- Sufentanil CitrateExisting use: Pain46.8% AI-predicted activityagainst E. coli50+ registered studies
- SuvorexantExisting use: Insomnia46.7% AI-predicted activityagainst E. coli50+ registered studies
- Ceruletide DiethylamineExisting use: Tests for bile duct patency46.7% AI-predicted activityagainst E. coliNo documented evidence found
- Aripiprazole LauroxilExisting use: Aggressive behavior, Agitation, Autism and 8 more46.7% AI-predicted activityagainst E. coli10 registered studies
- VericiguatExisting use: Cardiovascular disease, Heart failure46.7% AI-predicted activityagainst E. coli50+ registered studies
- Lomitapide MesylateExisting use: Familial hypercholesterolemia, Homozygous familial hypercholesterolemia, Hypercholesterolemia46.5% AI-predicted activityagainst E. coliNo documented evidence found
- CobicistatExisting use: HIV infection, HIV-1 infection, Infection46.4% AI-predicted activityagainst E. coli50+ registered studies
- OmaveloxoloneExisting use: Friedreich ataxia46.4% AI-predicted activityagainst E. coli25 registered studies
- Lanreotide AcetateExisting use: Acromegaly, Carcinoid syndrome46.4% AI-predicted activityagainst E. coli50+ registered studies